JP Morgan Chase’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
99,860
-450,038
-82% -$4.88M ﹤0.01% 4611
2026
Q1
$5.95M Buy
549,898
+500,082
+1,004% +$5.38M ﹤0.01% 3156
2025
Q4
$533K Buy
49,816
+82
+0.2% +$874 ﹤0.01% 4969
2025
Q3
$527K Sell
49,734
-175,541
-78% -$1.86M ﹤0.01% 4993
2025
Q2
$2.38M Buy
+225,275
New +$2.36M ﹤0.01% 3774

Other funds holding GPAT

JP Morgan Chase's GPAT Position: Q2 2026 in Review

JP Morgan Chase reduced its GP-Act III Acquisition Corp (GPAT) stake by 82% in Q2 2026, selling an estimated $4.88M and leaving 99,860 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #4611.

JP Morgan Chase first reported a position in GPAT in Q2 2025 and has held it in 5 quarters since. The position peaked at $5.95M in Q1 2026. 24 funds tracked by Wall St. Rank hold GPAT as of Q2 2026.

  • JP Morgan Chase held 99,860 shares of GP-Act III Acquisition Corp worth $1.09M as of Q2 2026.
  • JP Morgan Chase sold 450,038 GP-Act III Acquisition Corp shares in Q2 2026, an estimated $4.88M.
  • GP-Act III Acquisition Corp made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #4611 holding.
  • JP Morgan Chase first reported a position in GP-Act III Acquisition Corp in Q2 2025 and has held it in 5 quarters since.
  • JP Morgan Chase's GP-Act III Acquisition Corp position peaked at $5.95M in Q1 2026.
  • 24 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.